Ibio Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
All right. Hello, everyone. Welcome to day three of our Oppenheimer Healthcare Conference and thanks for joining us today. My name is Daniel [Thengone], I am a biotech research associate here at Oppenheimer. And it's my pleasure to introduce iBio. iBio is a plant-based biopharmaceutical company that is leveraging its FastPharming technologies to develop novel biopharmaceuticals in oncology, fibrotic diseases and infectious diseases.
From the company, we have CEO and Chairman, Tom Isett, to present. In terms of the format here, we'll have the company present for about 20, 25 minutes, followed by some time for Q&A. Please feel free to send over questions using the Q&A chat at the bottom of your screen, and I'll do my best to get to all of them.
With that, thank you very much, Tom, for joining us today, and please take it away.
Great. Thanks, Daniel, and happy Thursday to you and everybody. Thanks for joining. We're going to be,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |